Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.26 USD | +0.23% | +2.46% | +21.27% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
Financials (USD)
Sales 2024 * | 10.91B | Sales 2025 * | 11.22B | Capitalization | 14.32B |
---|---|---|---|---|---|
Net income 2024 * | 1.6B | Net income 2025 * | 1.88B | EV / Sales 2024 * | 1.83 x |
Net Debt 2024 * | 5.69B | Net Debt 2025 * | 4.95B | EV / Sales 2025 * | 1.72 x |
P/E ratio 2024 * |
8.2
x | P/E ratio 2025 * |
7.03
x | Employees | 1,743 |
Yield 2024 * |
2.26% | Yield 2025 * |
2.34% | Free-Float | 96.8% |
Latest transcript on Ovintiv Inc.
1 day | +0.23% | ||
1 week | +2.46% | ||
Current month | +2.62% | ||
1 month | +4.02% | ||
3 months | +24.27% | ||
6 months | +10.68% | ||
Current year | +21.27% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 53.26 | +0.23% | 1,139,322 |
24-04-25 | 53.14 | +0.45% | 1,573,447 |
24-04-24 | 52.9 | +0.25% | 2,115,781 |
24-04-23 | 52.77 | +1.13% | 1,636,236 |
24-04-22 | 52.18 | +0.38% | 2,049,676 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.27% | 14.32B | |
+11.22% | 306B | |
+12.21% | 153B | |
+51.38% | 124B | |
+22.70% | 83.43B | |
+12.20% | 78.06B | |
+19.56% | 62.81B | |
+13.52% | 60.08B | |
+12.74% | 49.91B | |
+33.97% | 37.05B |
- Stock Market
- Equities
- OVV Stock